BIM
ADMS

BlackRock Investment Management’s Adamas Pharmaceuticals ADMS Stock Holding History

BlackRock Investment Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.15M Buy
68,213
+190
+0.3% +$2.94K ﹤0.01% 2615
2016
Q3 		$1.12M Sell
68,023
-118
-0.2% -$1.79K ﹤0.01% 2593
2016
Q2 		$1.03M Buy
68,141
+18,365
+37% +$303K ﹤0.01% 2614
2016
Q1 		$720K Buy
49,776
+9,068
+22% +$153K ﹤0.01% 2707
2015
Q4 		$1.15M Buy
40,708
+204
+0.5% +$3.43K ﹤0.01% 2489
2015
Q3 		$678K Buy
40,504
+1,346
+3% +$30.6K ﹤0.01% 2884
2015
Q2 		$1.03M Buy
39,158
+30,588
+357% +$595K ﹤0.01% 2742
2015
Q1 		$150K Buy
8,570
+58
+0.7% +$994 ﹤0.01% 3259
2014
Q4 		$148K Hold
8,512
– – ﹤0.01% 3291
2014
Q3 		$158K Buy
8,512
+731
+9% +$12.6K ﹤0.01% 3264
2014
Q2 		$142K Buy
+7,781
New +$139K ﹤0.01% 3261

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock Investment Management's ADMS Position: Q4 2016 in Review

BlackRock Investment Management increased its Adamas Pharmaceuticals (ADMS) stake by 0.28% in Q4 2016, buying an estimated $2.94K and bringing the position to 68,213 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

BlackRock Investment Management first reported a position in ADMS in Q2 2014 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

  • BlackRock Investment Management held 68,213 shares of Adamas Pharmaceuticals worth $1.15M as of Q4 2016.
  • BlackRock Investment Management bought 190 Adamas Pharmaceuticals shares in Q4 2016, an estimated $2.94K.
  • Adamas Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2615 holding.
  • BlackRock Investment Management first reported a position in Adamas Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.